Multispectral Optoacoustic Tomography for Advanced Imaging of Centronuclear Myopathy

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age2+
SponsorUniversity of Erlangen-Nürnberg Medical School

About this trial

Twenty patients with centronuclear myopathy and twenty age- and sex-matched, muscle-healthy controls will undergo diagnostic examination. Study participants will undergo physical examination, clinical and functional testing, and multispectral optoacoustic tomography (MSOT) scanning at predefined muscle sites (paraspinal muscles, trapezius muscle, deltoid muscle, forearm flexors, quadriceps muscle, adductor muscles, ischiocrural muscles, triceps surae muscle, and tibialis anterior).

Eligibility criteria

Qualifiers

None

Disqualifiers

Pregnancy

Nursing mothers

Tattoo in the area of the examination field

Subcutaneous fatty tissue > 3 cm

Trial design

Treatments tested in this trial

  • MSOT

Treatment groups

40 Participants
are divided into 2 treatment groups